Kirsten Fischer Selected Research

Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)

1/2022

Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kirsten Fischer Research Topics

Disease

66	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2024 - 10/2009
13	Residual Neoplasm 05/2023 - 03/2017
11	Neoplasms (Cancer) 05/2022 - 05/2011
8	Infections 05/2024 - 03/2014
8	Disease Progression 05/2023 - 01/2015
7	Neutropenia 01/2022 - 03/2014
2	Lymphoma (Lymphomas) 12/2023 - 06/2016
2	Tumor Lysis Syndrome 05/2022 - 12/2020
2	Atrial Fibrillation 01/2022 - 01/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2023
1	T-Cell Leukemia (Leukemia, T Cell) 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2022
1	Myocardial Infarction 01/2022
1	Hemorrhage 01/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Leukemia 01/2022
1	Exanthema (Rash) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021
1	Genomic Instability 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Leukocytosis (Pleocytosis) 01/2021
1	Multiple Myeloma 01/2021
1	Lymphoid Leukemia 12/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Obesity 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	COVID-19 01/2020
1	Trisomy (Trisomies) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2019
1	Leukoencephalopathies 10/2017
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2017
1	Mucositis 06/2016
1	Carcinogenesis 10/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2011
1	Pathologic Complete Response 02/2011
1	Body Weight (Weight, Body) 10/2009

Drug/Important Bio-Agent (IBA)

22	Rituximab (Mabthera)FDA Link 05/2024 - 09/2011
21	obinutuzumabIBA 04/2024 - 03/2014
18	venetoclaxIBA 10/2023 - 11/2017
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 08/2013
14	fludarabineIBA 05/2024 - 10/2009
12	ibrutinibIBA 05/2023 - 01/2015
9	Bendamustine Hydrochloride FDA Link 04/2024 - 09/2011
7	Chlorambucil (Leukeran)FDA Link 10/2023 - 10/2009
4	idelalisibIBA 04/2024 - 03/2018
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2011
3	AntibodiesIBA 05/2023 - 12/2020
3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 05/2015
3	Lenalidomide (CC 5013)FDA Link 01/2021 - 09/2016
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2022
2	tirabrutinibIBA 06/2022 - 04/2022
2	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 11/2020
2	ofatumumab FDA Link 01/2021 - 03/2018
2	Thymidine KinaseIBA 01/2020 - 01/2018
1	Drug CombinationsIBA 05/2024
1	serum P-component (CIt)IBA 01/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	Histone DemethylasesIBA 01/2023
1	6- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA 04/2022
1	Vincristine (Oncovin)FDA LinkGeneric 02/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022
1	Prednisone (Sone)FDA LinkGeneric 02/2022
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Cytochrome P-450 CYP3AIBA 01/2022
1	acalabrutinibIBA 01/2021
1	hydrogen sulfite (bisulfite)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 12/2020
1	pipoxolan (BR 18)IBA 02/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Genetic Markers (Genetic Marker)IBA 10/2017
1	Alemtuzumab (Campath)FDA Link 03/2017
1	Dihydrotachysterol (AT 10)IBA 03/2017
1	Cisplatin (Platino)FDA LinkGeneric 06/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2016
1	Oxygen (Dioxygen)IBA 06/2016
1	purineIBA 06/2015
1	Tyrosine Kinase InhibitorsIBA 05/2015
1	HLA-DR Antigens (HLA-DR)IBA 05/2011

Therapy/Procedure

19	Therapeutics 04/2024 - 10/2009
6	Drug Therapy (Chemotherapy) 12/2023 - 02/2011
2	Aftercare (After-Treatment) 01/2018 - 01/2016
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Duration of Therapy 03/2018